U.S., March 3 -- ClinicalTrials.gov registry received information related to the study (NCT07443202) titled 'Study of Lotilaner Ophthalmic Gel in Patients With Ocular Rosacea (KORE)' on Feb. 24.
Brief Summary: To evaluate lotilaner treatment in patients with ocular rosacea.
Study Start Date: Dec. 05, 2025
Study Type: INTERVENTIONAL
Condition:
Ocular Rosacea
Intervention:
DRUG: lotilaner
lotilaner
DRUG: Vehicle
Vehicle of lotilaner
Recruitment Status: ENROLLING_BY_INVITATION
Sponsor: Tarsus Pharmaceuticals, Inc.
Published by HT Digital Content Services with permission from Health Daily Digest....